Insider trade

Merck (MRK): Officer exercised options on 1,967 shares

Chirfi Guindo, Officer at Merck, reported an option exercise of 1,967 shares.

1,967
Shares · @ $110.03
Traded
Apr 29, 2026
Filed
May 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 4, 2026CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  2. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  3. Mar 27, 2026CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  4. Apr 15, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  5. Apr 24, 2026FDAFDA drug approval: Keytruda Qlex

What came next

  1. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  2. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  3. May 4, 2026Federal contract · $43K obligatedDepartment of Veterans Affairs awarded Merck: $43K obligated to date
  4. May 8, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  5. May 11, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  6. May 11, 2026Federal contract · $342K obligatedDepartment of Veterans Affairs awarded Merck: $342K obligated to date
  7. May 21, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  8. Jun 12, 2026FDAFDA drug approval: Welireg
  9. Jun 12, 2026FDAFDA drug approval: Keytruda
  10. Jun 12, 2026FDAFDA drug approval: Keytruda Qlex
  11. Jun 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  12. Jun 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  13. Jun 23, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
  14. Jun 24, 2026FDAFDA drug approval: Keytruda
  15. Jun 24, 2026FDAFDA drug approval: Keytruda Qlex
  16. Jul 10, 2026FDAFDA drug approval: Keytruda
  17. Jul 10, 2026FDAFDA drug approval: Keytruda Qlex
  18. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
  19. Aug 5, 2026Insider · 2 peopleInsiders: 6 sales (~$9.2M)
  20. Aug 6, 2026Insider · 2 peopleInsiders: 4 sales (~$2.8M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Merck

For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

Other recent filings by Chirfi Guindo, EVP, Access, Policy & Comms

The full history of Chirfi Guindo, EVP, Access, Policy & Comms is on the profile page.

How this filing works

Explore the data

Common questions

Which Merck (MRK) insider traded, and how much?

Chirfi Guindo, Officer at Merck, reported an option exercise of 1,967 shares. At $110.03.

When did it happen, and when was it made public?

Traded: Apr 29, 2026. Filed: May 1, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Merck recently?

For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MRK page.

Does this mean MRK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Merck

Everything OQRO holds on this company is on its MRK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data